Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Заявленная компания
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions читать еще
Alignment to the key priorities, the four core programs.
Чем вы больше всего довольны в вашем пакете компенсаций?
The salary is the best part of the compensation package.
Что вам больше всего нравится в команде руководства?
The ET has the best interest of the company in mind, aligned with the key priorities.
Каковы самые лучшие качества в вашей команде?
They all have the best intentions, doing what they can to make Karyopharm a better place.
Other Employee Reviews for Karyopharm Therapeutics
×